ArticleInternational journal of general medicine2025
Clinical Features, Course and Prognosis of Kounis Syndrome.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Kounis Syndrome in the Modern Era: A Comprehensive Review of Allergic Acute Coronary Syndromes.Journal of clinical medicine · 2026Review
- Role of Troponins in CardioOncology.Current treatment options in oncology · 2026Review
- Mixed Shock due to Sepsis and Anaphylactic Reaction With Kounis Syndrome Secondary to Dipyrone (Metamizole): Case Report.Case reports in critical care · 2026Article
- Kounis Syndrome Presenting with Atrial Fibrillation and Shark-Fin ST Elevation After Multiple Bee Stings in an African Patient: A Case Report.International medical case reports journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Allergic myocardial infarction, known as Kounis Syndrome (KS), is a significant cause of acute coronary syndrome. However, the management and outcomes of KS are not clear. Thus, we aimed to investigate demographic characteristics, clinical features, laboratory findings, prognosis, and outcomes of patients with KS. Methods: Between January 2018 and December 2024, all consecutive patients who were diagnosed with KS were retrospectively analyzed. The precipitating factors, laboratory, ECG, and echocardiographic findings at presentation, in-hospital, and long-term outcomes were examined. Follow-up data were acquired from the hospital database and telephone interviews. Results: Twenty-eight patients with KS (18 men, mean age 47.7±14.3 years) were included in the study. Allergic symptoms such as pruritus, and cardiac symptoms such as chest pain, palpitation, and dyspnea were the most common presenting symptoms. Type 1 KS was the most frequent form (89.3%) of the disease. The most frequent triggering factor was drugs (71.4%), followed by a bee or insect stings (14.3%). Of the study population, 78.6% had left ventricular (LV) wall motion abnormality at presentation, which completely recovered in 92.9% of the patients within a few weeks. No cases of mortality occurred during the follow-up among patients with KS. Conclusion: This is the largest series of patients with KS. The results of this study showed that drugs and insect/hymenoptera stings were the most common triggering factors in KS. Compared to atherosclerotic acute coronary syndromes, in-hospital and long-term prognosis were better in patients with KS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.